Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Balance Sheets (Parenthetical)

v3.24.2.u1
Condensed Consolidated Balance Sheets (Parenthetical) - USD ($)
Jun. 30, 2024
Dec. 31, 2023
Debt Instrument [Line Items]    
Net of accumulated depreciation $ 101,000 $ 99,000
Common stock, par value $ 0.001 $ 0.001
Common stock, shares authorized 500,000,000 500,000,000
Common stock, shares issued 402,081,800 392,586,471
Common stock, shares outstanding 402,081,800 392,586,471
Convertible Notes Payable [Member]    
Debt Instrument [Line Items]    
Convertible notes payable, net of discounts $ 74,000 $ 25,000
Convertible notes past due $ 2,200,000 $ 2,022,000